About James Ryaby
Form D filings for Chrysalis Biotherapeutics in 2024 list James Ryaby as director.
James Ryaby first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name James Ryaby in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Ryaby works with at each company, as listed on that company's latest Form D.
Chrysalis Biotherapeutics, Inc. · Form D, Mar 22, 2024
LS
Lauri Sower
Executive officer
DC
Darrell Carney
President and director
TS
Timothy Schmidt
Director
MR
Marie Robb
Director
JS
Jeffery Sheldon
Director